Clinical Trials Directory

Trials / Completed

CompletedNCT06756113

Digital Dyadic Empowerment Program on Lifestyle Modification for Chronic Kidney Disease Management

Digital Dyadic Empowerment Program (DDEP) on Lifestyle Modification for Chronic Kidney Disease Management: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
208 (actual)
Sponsor
National Cheng Kung University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to find out if the Digital Dyadic Empowerment Program (DDEP) can help people with chronic kidney disease (CKD) and their care partners make healthy lifestyle changes. The main questions this study will answer are: * Does DDEP help protect kidney function? * Does DDEP support healthier daily habits? Researchers will compare two groups: * One group will receive the DDEP and get usual medical care. * The other group will get usual medical care only. Participants will: * Receive usual care with or without DDEP for six months. * Visit the clinic at the start and end of the study for health checks and tests. * Practice healthy habits at home with or without help from DDEP. This study aims to show if adding DDEP to regular care can make it easier for people with CKD and their care partners to live healthier lives.

Detailed description

This randomized controlled trial (RCT) aims to evaluate the long-term effects of the Digital Dyadic Empowerment Program (DDEP) in comparison to routine care for people with chronic kidney disease (CKD) and their significant others. The study will assess whether the DDEP can improve health outcomes such as kidney function, health-promoting lifestyle behaviors, and the quality of relationships between significant others over a six-month period. The trial will follow the Consolidated Standards of Reporting Trials (CONSORT) 2010 and CONSORT-EHEALTH guidelines to ensure rigorous reporting and transparency. Baseline assessments will occur in a private clinic room and will include demographic information, disease-related characteristics, and self-reported measures. Participants in both groups will also complete the Trans-Theoretical Model (TTM) staging inventory to evaluate their readiness for lifestyle changes. Dyads assigned to the intervention group will receive DDEP setup instructions and training on platform use during the baseline visit. Throughout the study, dyads will be encouraged to utilize the platform for self-management tasks at home, including diet tracking, exercise planning, and monitoring blood pressure.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDigital Dyadic EmpowermentThe Digital Dyadic Empowerment Intervention utilizes LINE, a prominent instant messaging App in Taiwan, integrated with an extended application to deliver comprehensive lifestyle modification support to Chronic Kidney Disease (CKD) dyads. Key features of this intervention include: 1. Access to CKD Health Education Information; 2. Supportive Information for Significant Others; 3. Physiological Values Logging for Self-Monitoring; 4. Reminders for Clinical Appointments and Daily Self-Management Tasks; 5. Kidney Health Diary for Lifestyle Modification Progress Tracking; 6. Frequently Asked Questions (FAQs) and Consultation with Healthcare Providers. This intervention aims to enhance the overall well-being of CKD dyads by promoting education, self-monitoring, adherence to appointments, and efficient communication with healthcare providers.
BEHAVIORALUsual CareAll patients in this study received regular nephrology care at National Cheng Kung University Hospital. Nephrologists conducted routine examinations and provided diagnoses based on test results. The patient's condition (e.g., changes in kidney function), treatment plan, prognosis, and risks were explained to both the patient and family members. The treatment plan included medication, monitoring blood pressure, dietary and exercise at home, and consultations with the Health Education Center for kidney care or nutrition advice.

Timeline

Start date
2025-01-13
Primary completion
2025-10-08
Completion
2025-10-15
First posted
2025-01-01
Last updated
2026-02-12
Results posted
2026-02-12

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06756113. Inclusion in this directory is not an endorsement.